About: Hospital La Paz Institute for Health Research

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Hospital La Paz Institute for Health Research Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

healthcare organization in Madrid, Spain

Attributes	Values
rdf:type	Item
description	griya sakit (jv) rumah sakik (min) rumoh sakét (ace) rumah sakit di Spanyol (id) مستشفى في مدريد، إسبانيا (ar) healthcare organization in Madrid, Spain (en) Organización de investigación sanitaria en Madrid (es)
rdfs:label	Hospital La Paz Institute for Health Research (en) Instituto de Investigación Sanitaria Hospital La Paz (es)
skos:prefLabel	Hospital La Paz Institute for Health Research (en) Instituto de Investigación Sanitaria Hospital La Paz (es)
name	Hospital La Paz Institute for Health Research (en) Instituto de Investigación Sanitaria Hospital La Paz (es)
ROR ID	wds:Q30293330-A7BDD20B-3E98-4E8A-8818-188CDEFE6193
ROR ID	017bynh47
instance of	wds:Q30293330-8D0A85C0-BCF6-4526-8738-5F0B7609887B wds:Q30293330-A84D5DBF-242F-4230-9B7E-964BB77E010E
instance of	hospital medical organization
country	wds:Q30293330-05BFBFB0-658D-4437-ACE2-178D57BD3421
country	Spain
skos:altLabel	Instituto de Investigación Sanitaria del Hospital Universitario La Paz (es) IdiPaz (es)
located in the adm...erritorial entity	wds:Q30293330-5A6A23A7-6A1E-420D-AC6B-179CA0A22B4E
member of	wds:Q30293330-89B7B56E-6290-4263-93CC-59A7ED0A0ADB
coordinate location	wds:Q30293330-74a82cd7-440b-89ec-eeb4-cf54a6f9f6f1
located in the adm...erritorial entity	Madrid
member of	Coalition for Advancing Research Assessment
coordinate location	POINT(-3.6884722222222 40.482388888889)
GRID ID	wds:Q30293330-891E8FB4-5B35-4AB9-ABB1-D2F9B26A5514
GRID ID	grid.440081.9
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q30293330
is research site of	Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in Spain Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy Patients Visit Prior to Hospital Admission & Intensive Care Unit Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2) Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours Open-Label, 48 Week Extension Study of Elvucitabine in Combination With Background ART For Subjects Who Have Completed Study ACH443-014A Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL) Etanercept Survival in Elderly Population Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer Pulmonary Embolism as a Cause of COPD Exacerbations Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC A Study to Observe Vedolizumab Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants A Study to Evaluate the Impact of Apremilast (CC-10004) on MRI Outcomes in Subjects With Psoriatic Arthritis Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis Nordic and Spanish Randomized Trial on the Effect of Revascularization or Optimal Medical Therapy of Chronic Total Coronary Occlusions With Myocardial Ischemia Hemopatch Performance Evaluation: A Prospective Observational Registry Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer A Study to Assess Disease Burden, in Terms of Health-related Quality of Life and Direct Healthcare Costs, in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Autologous Stem Cell Transplant (ASCT) in Spain FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients Secondary Prevention of Small Subcortical Strokes Trial Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects Non-interventional Study on Patients With Atrial Fibrillation and Cancer Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation Trial Comparing BST-CarGel and Microfracture in Repair of Articular Cartilage Lesions in the Knee Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations BI 655130 Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis Calcium Dobesilate for Chronic Venous Wounds Shockless Implant Evaluation Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02) Strategic Timing of Antiretroviral Treatment Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA) SOURCE XT REGISTRY EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention. Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M (BOOSTER) Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity Conditioning Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment PoC Study of OBE022 in Threatened Preterm Labour Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy. Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors Clinical and Virological Outcome of European Patients Infected With HIV PeriOperative ISchemic Evaluation-3 Trial Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke Phase 3 Extension Study of Dexpramipexole in ALS A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa Study of LM11A-31-BHS in Mild-moderate AD Patients TPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer. Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) Lenalidomide vs Placebo Maintenance Therapy Following Melphalan Prednisone Velcade® Induction Therapy in NDMM

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software